Anti-inflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial

Objectives: To assess the effect of two similar olive oils, but with differences in their phenolic compounds (powerful antioxidant compounds), on inflammatory markers in stable coronary heart disease patients. Design: Placebo-controlled, crossover, randomized trial. Setting: Cardiology Department of...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical nutrition Vol. 62; no. 4; pp. 570 - 574
Main Authors Fitó, M, Cladellas, M, Torre, R. de la, Marti, J, Munoz, D, Schroder, H, Alcantara, M, Pujadas-Bastardes, M, Marrugat, J, López-Sabater, M.C
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.04.2008
Nature Publishing
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives: To assess the effect of two similar olive oils, but with differences in their phenolic compounds (powerful antioxidant compounds), on inflammatory markers in stable coronary heart disease patients. Design: Placebo-controlled, crossover, randomized trial. Setting: Cardiology Department of Hospital del Mar and Institut Municipal d'Investigació Mèdica (Barcelona). Subjects: Twenty-eight stable coronary heart disease patients. Interventions: A raw daily dose of 50 ml of virgin and refined olive oil (ROO) was sequentially administered over two periods of 3-weeks, preceded by 2-week washout periods in which ROO was used. Results: Interleukin-6 (P<0.002) and C-reactive protein (P=0.024) decreased after virgin olive oil intervention. No changes were observed in soluble intercellular and vascular adhesion molecules, glucose and lipid profile. Conclusions: Consumption of virgin olive oil, could provide beneficial effects in stable coronary heart disease patients as an additional intervention to the pharmacological treatment.
Bibliography:http://dx.doi.org/10.1038/sj.ejcn.1602724
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0954-3007
1476-5640
DOI:10.1038/sj.ejcn.1602724